Regeneron Pharmaceuticals (REGN)
Add to Watchlists Create an Alert
254.87
-7.55 -2.88%
NASDAQ
May 23, 8:00PM
BATS Real time
Currency in USD
Regeneron Pharmaceuticals Interest Expense:
11.68M for March 31, 2013Regeneron Pharmaceuticals Historical Interest Expense Data
Pro Data Export
Dates:
to
There is no data for the selected date range.
| Data for this Date Range | |
|---|---|
| March 31, 2013 | 11.68M |
| Dec. 31, 2012 | 11.50M |
| Sept. 30, 2012 | 11.41M |
| June 30, 2012 | 11.24M |
| March 31, 2012 | 11.16M |
| Dec. 31, 2011 | 9.455M |
| Sept. 30, 2011 | 4.061M |
| June 30, 2011 | 4.047M |
| March 31, 2011 | 3.719M |
| Dec. 31, 2010 | 2.458M |
| Sept. 30, 2010 | 2.234M |
| June 30, 2010 | 2.342M |
| March 31, 2010 | 2.084M |
| Dec. 31, 2009 | 1.756M |
| Sept. 30, 2009 | 0.581M |
| June 30, 2009 | 0.00 |
| March 31, 2009 | 0.00 |
| Dec. 31, 2008 | 0.00 |
| Sept. 30, 2008 | 0.00 |
| June 30, 2008 | 2.674M |
| March 31, 2008 | Go Pro |
| Dec. 31, 2007 | Go Pro |
| Sept. 30, 2007 | Go Pro |
| June 30, 2007 | Go Pro |
| March 31, 2007 | Go Pro |
| Dec. 31, 2006 | Go Pro |
| Sept. 30, 2006 | Go Pro |
| June 30, 2006 | Go Pro |
| March 31, 2006 | Go Pro |
| Dec. 31, 2005 | Go Pro |
| Sept. 30, 2005 | Go Pro |
| June 30, 2005 | Go Pro |
| March 31, 2005 | Go Pro |
| Dec. 31, 2004 | Go Pro |
| Sept. 30, 2004 | Go Pro |
| June 30, 2004 | Go Pro |
| March 31, 2004 | Go Pro |
| Dec. 31, 2003 | Go Pro |
| Sept. 30, 2003 | Go Pro |
| June 30, 2003 | Go Pro |
| March 31, 2003 | Go Pro |
| Dec. 31, 2002 | Go Pro |
| Sept. 30, 2002 | Go Pro |
| June 30, 2002 | Go Pro |
| March 31, 2002 | Go Pro |
| Dec. 31, 2001 | Go Pro |
| Sept. 30, 2001 | Go Pro |
| June 30, 2001 | Go Pro |
| March 31, 2001 | Go Pro |
| Dec. 31, 2000 | Go Pro |
About Interest Expense
When companies borrow money to expand or maintain their business operations, they must pay interest on the money that they borrow. The interest expense is the annual accrued amount of interest that the company paid (or sometimes will have to pay) to its creditors.
A higher interest expense means that the company is paying more to its debtors. In general, a company's capital structure with a heavier debt focus will have higher interest expenses. Liquidity ratios such as EBIT/Interest Expense can help investors see if increasing Interest Expenses are problematic.
YCharts includes both operating interest expense and non-operating interest expense in our numbers.
Learn More
REGN Interest Expense Benchmarks
| Companies | |
|---|---|
| Sanofi | 201.21M |
| Celgene Corporation | 17.90M |
| Exelixis | 11.06M |
REGN Interest Expense Rankings
| Overall |
42nd percentile 4594 of 8006 |
| Sector |
15th percentile 583 of 686 in Healthcare |
| Industry |
9th percentile 224 of 248 in Biotechnology |
REGN Interest Expense Range, Past 5 Years
| Minimum | 0.00 | Sep 2008 |
| Maximum | 11.68M | Mar 2013 |
| Average | 4.620M |
